Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
01/06/2026 08:01
BRIEF-Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker June 1 (Reuters) - Qlife Holding AB QLIFE.ST:
ENTERS FEASIBILITY AGREEMENT WITH GLOBAL PHARMA COMPANY FOR EGOO HEALTH BIOMARKER
FEASIBILITY AGREEMENT FULLY FUNDED BY PHARMA COMPANY
Source text: ID:nWkr6ZWwL9
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million